OCS
Price:
$19.7
Market Cap:
$828.38M
Oculis Holding AG, a clinical-stage biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. The company's lead candidate is OCS-01, a topical dexamethasone formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for keratoconjunctivitis sicca, or dry eye disease; and OCS-05, a novel neuroprotective agent for acute optic neuritis and other neuro-ophtha disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company is based in Zug, Switzerland.
Industry
Biotechnology
IPO Date
2021-05-18
Stock Exchange
NASDAQ
Ticker
OCS
According to Oculis Holding AG’s latest financial reports and current stock price. The company's current Enterprise Value is 765.15M. This represents a change of 21.82% compared to the average of 628.11M of the last 4 quarters.
The mean historical Enterprise Value of Oculis Holding AG over the last ten years is 387.73M. The current 765.15M Enterprise Value has changed 19.63% with respect to the historical average. Over the past ten years (40 quarters), OCS's Enterprise Value was at its highest in in the March 2025 quarter at 753.19M. The Enterprise Value was at its lowest in in the September 2021 quarter at 0.
Average
387.73M
Median
357.16M
Minimum
244.58M
Maximum
597.02M
Discovering the peaks and valleys of Oculis Holding AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 144.10%
Maximum Annual Enterprise Value = 597.02M
Minimum Annual Increase = -40.17%
Minimum Annual Enterprise Value = 244.58M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 597.02M | 144.10% |
| 2023 | 244.58M | -40.17% |
| 2022 | 408.83M | 14.46% |
| 2021 | 357.16M | 7.89% |
The current Enterprise Value of Oculis Holding AG (OCS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
416.81M
5-year avg
387.73M
10-year avg
387.73M
Oculis Holding AG’s Enterprise Value is less than Xencor, Inc. (1.46B), less than Kodiak Sciences Inc. (1.30B), less than AnaptysBio, Inc. (1.10B), less than UroGen Pharma Ltd. (1.17B), less than Phathom Pharmaceuticals, Inc. (913.24M), less than Nurix Therapeutics, Inc. (1.36B), less than Nektar Therapeutics (1.22B), less than Sana Biotechnology, Inc. (1.39B), greater than BridgeBio Oncology Therapeutics Inc. (517.22M), less than Mind Medicine (MindMed) Inc. (919.17M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.46B | $1.30B | |
| 1.30B | $1.31B | |
| 1.10B | $1.20B | |
| 1.17B | $1.14B | |
| 913.24M | $1.05B | |
| 1.36B | $1.39B | |
| 1.22B | $1.17B | |
| 1.39B | $1.38B | |
| 517.22M | $923.07M | |
| 919.17M | $939.13M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oculis Holding AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oculis Holding AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Oculis Holding AG's Enterprise Value?
What is the highest Enterprise Value for Oculis Holding AG (OCS)?
What is the 3-year average Enterprise Value for Oculis Holding AG (OCS)?
What is the 5-year average Enterprise Value for Oculis Holding AG (OCS)?
How does the current Enterprise Value for Oculis Holding AG (OCS) compare to its historical average?